Food News and Research

RSS

FDA extends PDUFA date for AstraZeneca's ticagrelor NDA

AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the New Drug Application (NDA) for ticagrelor (BRILINTA).

15 Sep 2010

Hunger costs developing nations $450B per year, report says

"Reduced worker productivity, poor health and lost education caused by malnourishment" is costing poor nations $450 billion a year, according to a report by the aid agency ActionAid, Agence France-Presse reports (9/13). The number is "more than 10 times the estimated amount needed to meet the United Nations Millennium Development Goal (MDG) of halving global hunger by 2015, said the report" according to the U.K. Press Association, which added that hunger also results in premature deaths (9/13).

15 Sep 2010

AMRI selects compound for advanced preclinical testing in treatment of IBS

AMRI today announced the selection of a compound from its proprietary research program for the treatment of irritable bowel syndrome (IBS) for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) in 2011.

15 Sep 2010

Ahead of MDG Summit, U.N. Secretary-General calls for additional funds, strategy for tackling women's and children's health issues

U.N. Secretary-General Ban Ki-moon on Monday announced that "nearly 140" world leaders are planning to attend next week's U.N. Millennium Development Goal (MDG) Summit in New York, where they will discuss ways to help countries reach the targets by 2015, the Canadian Press reports (Lederer, 9/13).

15 Sep 2010

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARC-4558 for the treatment of pain associated with Painful Diabetic Neuropathy (PDN).

15 Sep 2010

PLX-PAD therapy improves quality of life in CLI patients

Pluristem Therapeutics Inc. today reported that data from clinical trials show the Company's placenta-derived cell therapy, PLX-PAD, is safe and improves quality of life as well as other efficacy measurements in patients with Critical Limb Ischemia (CLI), the end-stage of Peripheral Artery Disease (PAD).

15 Sep 2010

Guardian launches global development website

The Guardian on Tuesday launched a new website that will cover global development issues, such as hunger and infant mortality, according to an introductory note on the site (Bunting, 9/14).

15 Sep 2010

Elsevier launches new Pharmacokinetics Module of PharmaPendium

Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium-, the online resource for authoritative drug development data.

15 Sep 2010

Opinions: Global nursing; U.S. funding of Global Fund; Global demands for water; Food security

"Almost every nation, regardless of its wealth and resources, faces a continuing shortage of nurses and an acute lack of nursing faculty available to educate more nurses. This dearth of practicing nurses and nurse educators is particularly critical in countries like Haiti and other developing high-risk, low-resourced nations," Martha Hill, dean of Johns Hopkins School of Nursing, writes in a Baltimore Sun opinion piece encouraging the expansion of global nursing.

15 Sep 2010

$Savient's KRYSTEXXA receives FDA approval for chronic gout in adult patients refractory to conventional therapy$

Savient's KRYSTEXXA receives FDA approval for chronic gout in adult patients refractory to conventional therapy

Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.

15 Sep 2010

FDA approves Krystexxa drug to treat gout

The U.S. Food and Drug Administration approved Krystexxa (pegloticase) to treat the painful condition known as gout in adults who do not respond to or who cannot tolerate conventional therapy.

15 Sep 2010

Life Technologies finalizes cell line license agreement for recombinant protein production

Life Technologies Corporation today announced that it has finalized cell line license agreements with a number of companies to provide rights to Life Technologies' proprietary CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines.

14 Sep 2010

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

Stemedica Cell Technologies, Inc., a world leader in adult stem cell manufacturing and research, announced today that it has completed its proprietary master bank of mesenchymal bone marrow-derived stem cells.

14 Sep 2010

E cigarettes tout best alternative to traditional tobacco cigarettes: Review

There has been talk around the world about the e cigarette and the difference it has been making in the lives of millions of smokers and non smokers alike. Touted as the smarter alternative to traditional tobacco cigarettes, e cigarettes have found a place in the hearts of millions of smokers who are thankful that they no longer have to inhale right at 4,000 chemicals that come with the combustion of tobacco cigarettes.

14 Sep 2010

SNE honors several members for their work in nutrition education

The Society for Nutrition Education honored several members for their work in nutrition education during the 2010 Annual Conference in Reno, Nevada, July 24 - 27, 2010. These awards were distributed to members for their dedication and excellence in nutrition education.

14 Sep 2010

CRA appeals to FDA for name change allowance in high fructose corn syrup labeling

In an effort to help clarify the labeling of food products for consumers, the Corn Refiners Association (CRA) today petitioned the U.S. Food and Drug Administration (FDA) to allow manufacturers the option of using 'corn sugar' as an alternative name for high fructose corn syrup.

14 Sep 2010

Researchers develop healthier, low saturated vegetable oil from soybeans

Years of research has proven that saturated and trans fats clog arteries, make it tough for the heart to pump and are not valuable components of any diet. Unfortunately, they are contained in many foods. Now, a University of Missouri research team has developed a soybean which produces oil that is naturally low in saturated and trans fats.

14 Sep 2010

More adults washing hands in public restrooms

In the latest observational study sponsored by the American Society for Microbiology and the American Cleaning Institute- (formerly The Soap and Detergent Association), 85% of adults washed their hands in public restrooms, compared with 77% in 2007. The 85% total was actually the highest observed since these studies began in 1996. The results were announced at the Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting sponsored by the American Society for Microbiology.

14 Sep 2010

Struggles lower-income older Americans face during recession

An AARP report released today for the first time paints a picture of the struggles lower-income older adults are facing during the recession. The AARP Closer Look June 2010 survey found that nearly six in 10 Americans 45+ who make less than $25,000 a year say they are either "not at all" or "not too" confident they will have enough money to pay medical and living expenses in retirement, compared to 36 percent of higher income adults.

14 Sep 2010

Emergency physicians to present research studies at Research Forum 2010

The risks associated with boarding admitted patients in the emergency department – including patient mortality – as well as proposed solutions will be key themes of Scientific Assembly, the annual meeting of the American College of Emergency Physicians. In addition, emergency physicians will present more than 450 research studies during 2010 Research Forum, the premier, annual scientific research event focused on the latest advances in the practice of emergency medicine.

14 Sep 2010